Developing Sample to Insight solutions to accelerate research on growing public health threat Hilden, Germany, Holzgerlingen, Germany, and Vienna, Austria –QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a broad agreement with Ares Genetics, a subsidiary of Curetis N.V. (Euronext: CURE), to develop innovative bioinformatics and assay solutions to accelerate research targeting the […]
A major publicly traded life science tools company has entered a technology assessment agreement with Phase Holographic Imaging (PHI). The purpose of the agreement is to assess PHI’s HoloMonitor technology for cell biology applications, primarily within immuno-oncology. The assessment is expected to extend over at least six months and to form the basis of the […]
Oxford: Oxford Genetics and Sphere Fluidics announce a multi-partner collaboration to expedite the development of automated microfluidic systems for rapid and high-throughput gene editing in mammalian cell lines. Under the agreement, Sphere Fluidics will act as the lead partner, looking to utilise its extensive expertise in microfluidic systems to produce new products designed to meet the […]
LEUVEN, BELGIUM – As an advocate for researchers in the genomics age, Integrated DNA Technologies (IDT) is expanding its courier zones to ensure that the highest-fidelity oligos are available in less time and at the same price, to more customers. UK scientists based in Cambridge, Oxford, and London—both inside and out of the M25 orbital—can now benefit […]
MGI, a subsidiary of BGI Group, announced it is expanding in the Middle East with a new office in Dubai to better serve partners and clients in the region. MGI’s expansion in the region will include UAE, Qatar and Saudi Arabia, serving universities, hospitals, healthcare institutions and other customers and partners throughout the Middle East. […]
Cellectricon, a collaborative services provider dedicated to advance drug discovery and research in the areas of chronic pain and neurodegenerative disease, is delighted to announce that we will participate in BonePainII, a European Innovative Training Network committed to promote frontline research, innovation and education within bone pain. Millions of Europeans and beyond suffer from bone […]
HERCULES, Calif.–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) […]
Collaboration Provides Personalised Healthcare Benefits to Patients and Contributes Diverse Data Samples for Research BC Platforms, a global leader in genomic data management and analytics, today announced it is providing its world leading genomics platform to Bumrungrad International, a multi-specialty hospital located in the heart of Bangkok, Thailand handling more than 1.1 million patients per year. […]
AMSBIO has established a comprehensive portfolio of knock-out cell lines and lysates generated with CRISPR/Cas9 technology. Using CRISPR/Cas9 gene editing technology for the generation of knock-out cell lines and cell lysates ensures the development of useful tools to validate antibody specificity and elucidate gene function. Knock-out cell lines and cell lysates are widely agreed to be the […]
Miami Cancer Institute, part of Baptist Health South Florida, implements Philips’ cloud-based comprehensive genomics platform to inform cancer treatment options through advanced diagnostic testing (next generation sequencing) to extend the reach of personalized oncology care Alliance with Philips enables new genomics lab at Miami Cancer Institute to accelerate the launch of TST170 NGS testing service […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
